← Back to Clinical Trials
Recruiting NCT07205692

NCT07205692 Multimorbidity and Cardiovascular Risk Factors After Renal Transplant

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07205692
Status Recruiting
Phase
Sponsor University Hospitals of Derby and Burton NHS Foundation Trust
Condition Kidney Transplant
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-09-05
Primary Completion 2027-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-09-05 with a primary completion date of 2027-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Who can participate? Any adults over the age of 18 who have received a kidney transplant at the research centre are eligible for recruitment within the first month after transplant What does the study involve? The study involves observing and gathering data to understand how the health of people who receive a kidney transplant changes over the first year. In particular the investigators are interested in the risk factors for heart disease and stroke, and how these change over the first year of transplant. The investigators are also interested in multiple health conditions, and how these impact patients after transplant. There are no interventions but there will be measurements of diagnoses, risk factors for heart disease and stroke, and assessments of physical fitness Blood pressure, BMI, routine blood tests as well as assessing muscle and fat changes, how fit patients are and what new health conditions they have. What are the possible benefits and risks of participating? There is no active treatment or intervention, so there are no risks of benefits compared to normal care. Where is the study run from? University Hospitals of Derby and Burton NHS trust, at the Royal Derby hospital Renal Department. When is the study starting and how long is it expected to run for? The study is expected to start 1/9/2025 and run for 2 years. Who is funding the study? The only costs of the study are funding for the staff member running the study, who is funded by the NIHR as an academic research fellow Who is the main contact? Dr Samuel Strain, Samuel.strain@nottingham.ac.uk

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years old * Capable of giving informed consent * In receipt of a single organ renal transplant and being followed up by UHDB as the referring team. Exclusion Criteria: • Graft failure before return to follow up

Contact & Investigator

Central Contact

Samuel Strain, BMBS

✉ samuel.strain@nhs.net

📞 +44 1283 566 333

Principal Investigator

Nicholas Selby

PRINCIPAL INVESTIGATOR

University of Nottingham and UHDB

Frequently Asked Questions

Who can join the NCT07205692 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07205692 currently recruiting?

Yes, NCT07205692 is actively recruiting participants. Contact the research team at samuel.strain@nhs.net for enrollment information.

Where is the NCT07205692 trial being conducted?

This trial is being conducted at Derby, United Kingdom.

Who is sponsoring the NCT07205692 clinical trial?

NCT07205692 is sponsored by University Hospitals of Derby and Burton NHS Foundation Trust. The principal investigator is Nicholas Selby at University of Nottingham and UHDB. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology